These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Emergence of fluoroquinolone-resistant tuberculosis in New York City. Sullivan EA, Kreiswirth BN, Palumbo L, Kapur V, Musser JM, Ebrahimzadeh A, Frieden TR. Lancet; 1995 May 06; 345(8958):1148-50. PubMed ID: 7723548 [Abstract] [Full Text] [Related]
10. Essential components of a tuberculosis control program within Australia. National Tuberculosis Advisory Committee. Commun Dis Intell Q Rep; 2014 Dec 31; 38(4):E397-400. PubMed ID: 25631607 [No Abstract] [Full Text] [Related]
11. Tuberculosis in Louisiana: an update. George RB, Farley TA, DeGraw CF, Owens MW. J La State Med Soc; 1998 Dec 31; 150(12):587-95. PubMed ID: 9926697 [Abstract] [Full Text] [Related]
12. The challenge of drug-resistant tuberculosis. Reichman LB. Cleve Clin J Med; 1994 Dec 31; 61(6):431-7. PubMed ID: 7828334 [Abstract] [Full Text] [Related]
13. Extensively drug-resistant tuberculosis: new strains, new challenges. Banerjee R, Schecter GF, Flood J, Porco TC. Expert Rev Anti Infect Ther; 2008 Oct 31; 6(5):713-24. PubMed ID: 18847407 [Abstract] [Full Text] [Related]
14. [Tuberculosis in the 21st centruy]. Casal M. Enferm Infecc Microbiol Clin; 2000 May 31; 18(5):207-8. PubMed ID: 10974762 [No Abstract] [Full Text] [Related]